Ontogeny of hepatic fatty acid-binding protein immunoreactivity in human liver and intestinal tract.
Liver and intestinal tissues of human fetuses at gestational ages between 6 and 30 weeks were immunostained with rabbit antibody against fatty acid-binding protein (FABP) isolated from rat liver, since the antibody crossreacted with human FABP of the hepatic type. FABP-immunoreactive hepatocytes were found in the liver as early as the 7th week of gestation, but not at the 6th week. The frequency of immunoreactive cells was about 80% throughout the gestational period examined. No immunoreactive cells other than hepatocytes were found in liver tissue. In the intestinal tract, ileal, colonic and vermiform appendicular FABP immunoreactivity was demonstrated at the 23rd week of gestation, and duodenal and jejunal immunoreactivity at the 26th week. Positive cells in the jejunum were very few at this stage, but numerous at the 30th week of gestation. The immunoreactive cells were primitive absorptive cells in intestinal villi, and no cryptic epithelial cells were positively immunostained. Thus, FABP immunoreactivity was considered to be a marker for hepatocytes at the early to late fetal stage, and for intestinal absorptive cells at mid- to late fetal stage.
D000818:Animals; D002352:Carrier Proteins / Q000276:immunology*; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D006801:Humans; D005779:Immunodiffusion; D007124:Immunoenzyme Techniques; D007422:Intestines / Q000276:immunology*; D008099:Liver / Q000276:immunology*; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D051381:Rats; D011919:Rats, Inbred Strains; D025521:Tumor Suppressor Proteins
D002352:Carrier Proteins; C107608:FABP7 protein, human; C490174:Fabp7 protein, rat; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D025521:Tumor Suppressor Proteins